PREVALENCE OF HEPATITIS B CARRIERS AND BLOOD GROUP FREQUENCY IN VOLUNTARY BLOOD DONORS

Nayla Tariq Chaudhry, Shahnaz Javed Khan, Tanvir Ali Khan, Munim Saeed, Maliha Syed, Javed Iqbal, Shahzjad Ahmed, Maleeha Saleem, Zunera Yaqub

Abstract


Infection with Hepatitis B virus is a serious hazard. A study was carried out to evaluate the prevalence rate of HBsAg carrier state among a group of 200 healthy voluntary blood donors. Blood groups and haemoglobin levels were also determined. The prevalence rate for HbsAg carrier suite was 2% (males-1.09%, females11.11%). The frequency distribution of ABO blood groups was: A- 22.7%, B- 36.35%, O- 33.85%>, and AB- 7.10%. The percentage distribution of Rh antigen was: Rh+ve- 93.44% and Rh-ve- 6.56%. Haemoglobin level, mean value ±standard deviation, for males was 13.84 ±0.95 and in case of females it was 13.02±0.53. The study reveals that females exhibit greater seropositivity, group B is the commonest and males have significantly higher Hb levels. In order to estimate HBV, blood and all blood products must be tested for HbsAg. Moreover, Hepatitis B vaccine should be included in the Expanded Programme of Immunization in our country. KEYWORDS: Hepatitis B, HbsAg, Blood groups, ABO, Rh(D), Haemoglobin

Full Text:

PDF

References


Deinhardt F, Abb J & Assad F. Viral hepatitis.

Bulletin of the WHO, 1983;61:203-6.

Vall Mayans M, Hall AJ, Inskip HM, et al. Risk

factors for transmission of hepatitis B virus to

Gambian children. Lancet 1990;336:1107-9.

Thursz MR, Kwiatkowski D & Alisopp CEM, et al.

Association between an MHC Class II allele and

clearance of hepatitis B virus in the Gambia. N Engl

J Med, 1995;332:1065-9.

Blumberg BS & Alter HJ. Precipitating antibodies

against a serum protein (Australia antigen in the

blood of a transfused haemophilia patient). J Clin

Inv, 1965;44:1029.

Zeldis JB, Shabib SM & Tufenkejl H. Diagnosis of

viral hepatitis (Editorial). Annals of Saudi Medicine,

; 15(1): 1-5.

Malik 1A, Tariq WVZ, Hassan ZU & Mahmood A.

Sub-classification of hepatitis B vims carriers.

JCPSP, 1996;6(1):4-5.

Attique MUH, Yousaf M, Haleem A & Hassan A.

Prevalence of hepatitis B virus in liver diseases in

Bahawalpur. JPGMI, 1990;4(1): 139-42.

Yousaf M & Yousaf N. Prevalence of hepatitis B

carriers among health care workers. Pak J Med Res,

;27:168-9.

Jabeen M, Hussain R, Siddiqui SA, Fayyaz A &

Saleem M.Prevalence of hepatitis B surface antigen

(HbsAg) in doctors, medical students and

paramedical staff working in Sir Ganga Ram

Hospital. Lahore. Pak J Med Res, 1995:34:172- 5

Alter MJ. Hadler SC & Margolis HS, et al. the

changing epidemiology of hepatitis B in United

States. JAMA, 1990;263:1218-22.

Parveen N. ABO and subgroup A in the Lahore

population. JPMA, 1987;37:200-1.

Jamal A. Ahmed MS. Ahmad A, Zafar MN & Syed

S. ABO and A subgroups in Karachi population.

JPMA, 1988;38:199-200.

Mustansar M & Ah I. Iron deficiency in women and

children specialists. Pak J Med Sci, 1995;

(4):323-5.

Hussain S, Khan AB, Ansari JK, Fazal I & Orakzai

A. Incidence and clinical aspects of hepatitis B in

naval hospital Karachi. PAFMJ, 1994;44(2):28-33.

Burney Ml. Spectrum of liver disease as studied at

the National Health Laboratories. National Seminar

on Liver Disease (Proceedings). PMRC Monograph

No 2, 1977;44.

Janjua IM & Hussain M. Hepatitis B vims surface

antigenaemia in voluntary blood donors and patients

with acute hepatitis. Pak J Med Res, 1990;29:160-2.

Malik 1A & Tariq WIJZ. Viral hepatitis in Pakistan

(Editorial). Pak J Path, 1993;4:1-5.

Lin HJ, Lai CL & Lau JYN. et al. Evidence for

intrafamilial transmission of hepatitis B virus from

sequence analysis of mutant HBV DNAs in two

Chinese families. Lancet, 1990;336:208-12.

Qureshi H. Post exposure prophylaxis of hepatitis B.

JPMA, March 1988;62-4

Nutritional anaemias. WHO Technical Report

Series, I972;502:29.

Dacies JV & Lewis SM. Practical Haematology.

Reference ranges and normal values. London, 7th

edition. Churchill Livingstone, 1991; 12.

Williams JR % Flowerdew ADS. Uptake of

immunization against hepatitis B among surgeons in

Wessex Regional Health Authority. BMJ,

:301:154.

Integrating hepatitis B vaccine into EPI programs

(WHO Special Report). Pak Paed J, 19; 17:85-7.


Refbacks

  • There are currently no refbacks.


Contact Number: +92-992-382571

email: [jamc] [@] [ayubmed.edu.pk]